159 related articles for article (PubMed ID: 30903272)
41. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
42. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis.
Liu Y; Liu T; Bao X; He M; Li L; Yang X
Int J Gynecol Pathol; 2014 May; 33(3):218-24. PubMed ID: 24681730
[TBL] [Abstract][Full Text] [Related]
43. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
44. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
45. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract][Full Text] [Related]
46. Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
Liang L; Zheng W; Liu J; Liang SX
Arch Pathol Lab Med; 2016 Feb; 140(2):148-52. PubMed ID: 26910219
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
Cameron RI; Maxwell P; Jenkins D; McCluggage WG
Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
[TBL] [Abstract][Full Text] [Related]
48. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
49. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
50. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
51. Atypical glandular lesions of the cervix and risk of cervical cancer.
Graue R; Lönnberg S; Skare GB; Saether SMM; Bjørge T
Acta Obstet Gynecol Scand; 2020 May; 99(5):582-590. PubMed ID: 31853943
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix.
El-Ghobashy AA; Shaaban AM; Herod J; Innes J; Prime W; Herrington CS
Gynecol Oncol; 2004 Feb; 92(2):628-34. PubMed ID: 14766257
[TBL] [Abstract][Full Text] [Related]
53. [Non-invasive lesions of the cervical glands. Apropos of a study of 431 conization specimens].
Chadli-Debbiche A; Philippe E; Ritter J; Baldauf JJ; Badre L; Bretz-Grenier MF; Rivasi F
Arch Anat Cytol Pathol; 1997; 45(1):5-12. PubMed ID: 9338998
[TBL] [Abstract][Full Text] [Related]
54. Cytologic findings in stratified mucin-producing intraepithelial lesion of the cervix: A report of 34 cases.
Backhouse A; Stewart CJ; Koay MH; Hunter A; Tran H; Farrell L; Ruba S
Diagn Cytopathol; 2016 Jan; 44(1):20-5. PubMed ID: 26493276
[TBL] [Abstract][Full Text] [Related]
55. HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.
Talia KL; Stewart CJR; Howitt BE; Nucci MR; McCluggage WG
Am J Surg Pathol; 2017 Aug; 41(8):1023-1033. PubMed ID: 28394803
[TBL] [Abstract][Full Text] [Related]
56. Symposium part 4: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Counterpoint.
Lee KR
Int J Gynecol Pathol; 2003 Jan; 22(1):22-4. PubMed ID: 12496693
[TBL] [Abstract][Full Text] [Related]
57. Endocervical atypical glandular cells of undetermined significance. I. Morphometric and cytologic characterization of cases that "cannot rule out adenocarcinoma in situ".
Cenci M; Mancini R; Nofroni I; Vecchione A
Acta Cytol; 2000; 44(3):319-26. PubMed ID: 10833985
[TBL] [Abstract][Full Text] [Related]
58. Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears.
Selvaggi SM; Haefner HK
Diagn Cytopathol; 1997 Feb; 16(2):168-73. PubMed ID: 9067112
[TBL] [Abstract][Full Text] [Related]
59. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
60. Performance of the cytologic examination for the diagnosis of endocervical adenocarcinoma in situ: cytologic-histologic correlation in 60 cases.
Zardo LM; Thuler LC; Zeferino LC; Horta NM; Fonseca Rde C
Acta Cytol; 2009; 53(5):558-64. PubMed ID: 19798884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
